New Delhi [India], December 14: Takeda Biopharmaceuticals India Pvt. Ltd. (formerly Baxalta Bioscience India Private Limited) - a global values-based, R&D-driven biopharmaceutical leader - presented an industry perspective on the substantial need for vaccine equity and novel strategies f
India on Sunday recorded 166 fresh COVID-19 cases while the number of total active cases stood at 895, according to data put out by the Union Health Ministry.
While speaking at the 96th Annual General Meeting (AGM) of the Federation of Indian Chambers of Commerce and Industry (FICCI), Jaishankar noted that history is on India's side and every measurable index is working in India's favour.
"Wait till tomorrow, they (Congress) will raise questions on EVM machines, as they are raising questions on exit polls. When Congress party faces defeat then they question Court, army, vaccines, exit polls and will raise questions on EVM tomorrow," Mishra said.
Dr Krishna Ella, Executive Chairman at Bharat Biotech, expressed enthusiasm about the agreement, stating, "This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology".
Bharat Biotech is a world-leading vaccine and biotherapeutics manufacturer. During the Covid pandemic, it made the vaccine Covaxin, which was administered by millions across the globe
Indian Immunologicals Ltd, a subsidiary of the National Dairy Development Board (NDDB) marked a significant milestone as its human health division, Human Biologicals Institute (HBI), celebrated its 25th year since its inception on Saturday.
Nottingham [England], November 22: The FDA on 10th November 2023 announced the approval of IXCHIQ®, Valneva's vaccine against the chikungunya virus. Notably, this is the first vaccine against the mosquito-borne disease to have been granted marketing approval by the FDA.
To integrate pandemic vaccines in national immunisation programme in countries of the WHO South-East Asia Region, vaccine regulators, and officials from WHO today began deliberating strategies to enable member countries to transition from the use of COVID-19 vaccines under Emergency Use Auth
Vaccines administered for COVID-19 did not increase the risk of sudden death among young adults in India but it was the post-Covid hospitalisation, family history of sudden death, and certain lifestyle behaviours that are likely the underlying causes, according to a peer-reviewed ICMR stu
The ministry of Health and Family welfare, Government on India said that the media reports claiming that "11 lakh children in India missed 1st measles shot in 2022" is incorrect and does not reflect the true picture.
A mechanism that caused some individuals to have fatal clotting after receiving certain forms of Covid-19 immunisation has been revealed in recent research.